ARS Pharmaceuticals, Inc. earnings per share and revenue

SPRY earnings per share for the last quarter are -0.13 USD whereas the estimation was -0.11 USD which accounts for -17.51% surprise. Company revenue for the same period amounts to 500.00 k USD despite the estimated figure of 1.00 M USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 575.00 k USD. Also watch annual changes over time to get a bigger picture of SPRY earnings per share and revenue dynamics.